About this trial
It is projected that by 2030, one in every five Americans will be of retirement age, and this demographic shift is expected to result in more people suffering from dementia. A key feature of the brain is its need for a constant supply of glucose and oxygen to meet the high energy costs of mental activity. This study aims to develop clinically practical, noninvasive imaging methods based on combined positron emission tomography and magnetic resonance imaging to assess brain energy in order to better understand how this critical component of brain health is impacted by aging.
Eligibility criteria
Qualifiers
Healthy Participants: Males and females, Age 21 - 80 years, BMI of 18.5-30
Disqualifiers
None
Trial design
Treatments tested in this trial
- Ketogenic Supplement
- Placebo Drink
Treatment groups
Sponsors and collaborators
University of Pennsylvania
Lead sponsor
National Institute of Neurological Disorders and Stroke (NINDS)
Collaborator
University of Western Ontario, Canada
Collaborator